Quality of life issues in patients with ductal carcinoma in situ: a systematic review.

Rajeswaran, T.; Gojsevic, M.; Chan, AW.; Wong, HCY.; Lee, SF.; Bernard, R.; Marta, GN.; Pogoda, K.; Kwan, JYY.; Kuszaj, O.; Day, M.; Behroozian, T.; Bleiker, EMA.; Wong, C.; Kikawa, Y.; Tane, K.; Velikova, G.; Marcou, Y.; Bjelic-Radisic, V.; Karam, I.; Al-Khaifi, M.; Kennedy, SKF.; Chow, E.

Quality of life issues in patients with ductal carcinoma in situ: a systematic review.

All Authors

Rajeswaran, T.

Gojsevic, M.

Chan, AW.

Wong, HCY.

Lee, SF.

Bernard, R.

Marta, GN.

Pogoda, K.

Kwan, JYY.

Kuszaj, O.

Show 10 more

LTHT Author

Velikova, Galina

LTHT Department

Leeds Cancer Centre

Publication Date

2024

Item Type

Journal Article
Systematic Review

Abstract

PURPOSE: Ductal carcinoma in situ (DCIS) of the breast is one of the most common pre-invasive cancers diagnosed in women. Quality of life (QoL) is extremely important to assess in studies including these patients due to the favorable prognosis of the disease. The primary objective of this systematic review was to compile a comprehensive list of QoL issues, all existing QoL assessment tools, and patient-reported outcome measures used to assess DCIS. METHODS: A search was conducted on Ovid MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases from inception to August 2023, using keywords such as "ductal carcinoma in-situ", "quality of life", and "patient-reported outcomes." QoL issues and QoL tools in primary research studies were extracted. RESULTS: A total of 67 articles identified issues pertaining to patients with DCIS spanning physical, functional, and psychosocial QoL domains. Physical and functional issues observed in patients included pain, fatigue, and impaired sexual functioning. Psychosocial issues such as anxiety, depression, and confusion about one's disease were also common. QoL tools included those that assessed general QoL, breast cancer-specific tools, and issue-specific questionnaires. CONCLUSION: The current instruments available to assess QoL in patients with DCIS do not comprehensively capture the issues that are pertinent to patients. Thus, the modification of existing tools or the creation of a DCIS-specific QoL tool is recommended to ensure that future research will be sensitive towards challenges faced by patients with DCIS.